Boehringer Ingelheim has opened a new inhaler plant in Spain just weeks after adding production lines to plants in Germany, expansions that bring its recent investments in the Respimat inhaler to about €225 million.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,